We found that the frequency of CD8+ T cells increased in blood (p = 0.0002) and lymph node (p = 0.022) from NSCLC patients compared to the normal group, while the frequency of CD4+ T cells declined in NSCLC-Ly group (p = 0.022). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.